|
|
|
| Total Value: $998,567.29 |
Cash Value: $128,446.39 |
Stock Value: $870,120.91 |
Shares: 100,000 |
Price: $9.99 |
|
|
| Fund Performance for aratnikas |
February 13, 2012 |
|
 |
fund information |
 |
|
| |
|
| Fund
Manager:
aratnikas |
Inception:
Sep 19, 2000 |
| Description: |
| Bio-Tech growth
I am a field engineer servicing medical equipment and am in major hospital labs every day. The outlook is favorable for the sector. Clinical labs are usually understaffed and always seeking better equipment to ease their work load. I look for companies that develop new harware for the clinical environment with track records for support and new product development. I am currently adding Tripath Imaging due to their pap smear tech and investments by Roche and Becton Dickinson. |
|
|
|
| |
|
|
|
|
Club Memberships |
|
|
|
|
|
| |
|
|
|
|
fund positions by sector
|
|
|
| |
|
|
| Color |
Name |
Portion |
 |
Financials |
2% |
 |
Health Care |
91% |
 |
Materials |
6% |
|
|
|
|
| |
|
|
|
|
fund positions by style |
|
|
| |
|
|
| Color |
Name |
Portion |
|
Large Cap Growth |
1% |
|
Large Cap Blend |
6% |
|
Large Cap Value |
7% |
 |
Mid Cap Growth |
6% |
 |
Mid Cap Blend |
4% |
 |
Mid Cap Value |
5% |
 |
Small Cap Growth |
5% |
 |
Small Cap Blend |
3% |
 |
Small Cap Value |
16% |
 |
Micro Cap Growth |
6% |
 |
Micro Cap Blend |
17% |
 |
Micro Cap Value |
24% |
|
|
|
| |
|
| |
| |
Value |
Blend |
Growth |
|
| Large |
7% | 6% | 1% | 14% |
| Medium |
5% | 4% | 6% | 15% |
| Small |
16% | 3% | 5% | 24% |
| Micro |
24% | 17% | 6% | 47% |
| |
52% | 30% | 18% |
|
|
|
|
|
| |
|
|
|
|
recent returns
|
|
|
| |
|
| RETURNS |
| Last Week |
-0.62% |
| Last Month |
9.34% |
| Last 3 Months |
14.62% |
| Last 6 Months |
18.47% |
| Last 12 Months |
15.85% |
| Last 2 Years |
39.00% |
| Last 3 Years |
77.62% |
| Last 5 Years |
11.33% |
| Since Inception |
-0.14% |
| (Annualized) |
-0.01% |
|
|
|
| S&P500 RETURNS |
| Last Week |
0.62% |
| Last Month |
5.02% |
| Last 3 Months |
8.04% |
| Last 6 Months |
14.44% |
| Last 12 Months |
3.87% |
| Last 2 Years |
30.92% |
| Last 3 Years |
74.24% |
| Last 5 Years |
3.44% |
| Since Inception |
14.85% |
| (Annualized) |
1.22% |
|
|
|
| RETURNS
VS S&P500 |
| Last Week |
-1.24% |
| Last Month |
4.32% |
| Last 3 Months |
6.58% |
| Last 6 Months |
4.03% |
| Last 12 Months |
11.98% |
| Last 2 Years |
8.08% |
| Last 3 Years |
3.38% |
| Last 5 Years |
7.89% |
| Since Inception |
-14.99% |
| (Annualized) |
-1.23% |
|
|
|
|
| |
|
|
|
|
fund rankings |
|
|
| |
|
For the six month period ending
September 30, 2011 Algis Ratnikas's Biotech Mutual Fund outperformed 87.5% of the other funds on our site. |
| |
|
|
| |
|
 Algis Ratnikas's Biotech Mutual Fund has been in the m100 (the list of the overall top 100 funds on our site)
2
times |
| |
|
|
| |
|
| ALL
RANKINGS FOR Algis Ratnikas's Biotech Mutual Fund |
| Date |
1 Month |
3 Months |
6 Months |
1 Year |
| Dec 31, 2000 |
|
46.5% |
|
|
|
|
|
| Mar 31, 2001 |
|
27.1% |
|
|
|
|
|
| Jun 30, 2001 |
|
|
N/C |
|
|
|
|
| Sep 30, 2001 |
|
32.4% |
|
|
|
|
|
| Dec 31, 2001 |
|
89.0%  |
|
|
|
|
|
| Mar 31, 2002 |
|
3.0% |
|
|
|
|
|
| Jun 28, 2002 |
81.3% |
24.9% |
11.2% |
26.2% |
|
|
|
| Sep 30, 2002 |
89.6% |
22.8% |
21.7% |
20.7% |
35.6% |
|
|
| Dec 31, 2002 |
34.1% |
21.7% |
9.5% |
6.0% |
27.9% |
|
|
| Mar 31, 2003 |
99.9% |
98.5% |
79.3% |
28.2% |
50.3% |
|
|
| Jun 30, 2003 |
18.1% |
89.5% |
96.7% |
87.8% |
37.9% |
|
|
| Sep 30, 2003 |
95.9% |
83.7% |
89.5% |
89.8% |
65.9% |
|
|
| Dec 31, 2003 |
61.7% |
22.9% |
66.3% |
93.3% |
18.7% |
48.0% |
|
| Mar 31, 2004 |
69.8% |
87.1% |
63.1% |
87.4% |
77.2% |
76.4% |
|
| Jun 30, 2004 |
9.2% |
40.7% |
78.2% |
76.7% |
90.3% |
47.3% |
|
| Sep 30, 2004 |
45.7% |
10.5% |
14.1% |
20.6% |
84.0% |
47.7% |
|
| Dec 31, 2004 |
98.2% |
74.5% |
17.0% |
41.8% |
91.2% |
21.5% |
|
| Mar 31, 2005 |
28.3% |
13.0% |
22.6% |
13.4% |
63.1% |
41.6% |
|
| Jun 30, 2005 |
77.0% |
99.1% |
69.9% |
41.2% |
63.3% |
83.8% |
|
| Sep 30, 2005 |
46.2% |
56.4% |
92.9% |
76.3% |
50.0% |
86.8% |
|
| Dec 31, 2005 |
86.4% |
37.6% |
49.0% |
63.8% |
54.5% |
90.8% |
46.6% |
| Mar 31, 2006 |
10.0% |
48.3% |
40.2% |
80.8% |
37.3% |
77.7% |
67.7% |
| Jun 30, 2006 |
18.3% |
5.0% |
4.9% |
9.2% |
14.5% |
36.9% |
30.1% |
| Sep 29, 2006 |
11.9% |
35.1% |
7.3% |
6.1% |
23.5% |
16.4% |
36.1% |
| Dec 29, 2006 |
28.6% |
63.5% |
44.4% |
8.6% |
22.1% |
21.9% |
15.1% |
| Mar 30, 2007 |
21.0% |
55.6% |
62.3% |
13.6% |
41.4% |
16.8% |
42.1% |
| Jun 29, 2007 |
13.0% |
8.8% |
16.7% |
22.5% |
7.4% |
10.4% |
52.9% |
| Sep 28, 2007 |
55.4% |
39.9% |
18.2% |
29.6% |
7.6% |
21.2% |
64.7% |
| Dec 31, 2007 |
10.5% |
30.9% |
32.2% |
21.6% |
9.0% |
16.5% |
64.0% |
| Mar 31, 2008 |
20.8% |
31.8% |
24.2% |
16.3% |
9.7% |
18.7% |
42.9% |
| Jun 30, 2008 |
75.2% |
44.9% |
37.4% |
29.4% |
20.1% |
11.3% |
24.3% |
| Sep 30, 2008 |
77.2% |
94.5% |
96.7% |
76.8% |
54.0% |
21.1% |
30.0% |
| Dec 31, 2008 |
69.5% |
50.9% |
84.4% |
78.7% |
49.9% |
26.4% |
31.8% |
| Mar 31, 2009 |
57.7% |
38.7% |
43.4% |
81.8% |
45.8% |
25.6% |
22.8% |
| Jun 30, 2009 |
99.4% |
72.6% |
59.8% |
92.8% |
75.8% |
55.1% |
28.5% |
| Sep 30, 2009 |
73.1% |
64.9% |
71.0% |
69.9% |
86.7% |
66.7% |
47.1% |
| Dec 31, 2009 |
79.0% |
12.2% |
30.8% |
49.2% |
84.3% |
51.5% |
31.6% |
| Mar 31, 2010 |
78.1% |
93.9% |
63.1% |
72.2% |
94.9% |
68.4% |
59.2% |
| Jun 30, 2010 |
36.9% |
33.9% |
77.4% |
58.2% |
92.0% |
78.5% |
33.5% |
| Sep 30, 2010 |
71.3% |
21.9% |
17.4% |
31.2% |
56.5% |
76.5% |
26.2% |
| Dec 31, 2010 |
92.3% |
66.8% |
42.7% |
66.5% |
57.1% |
85.5% |
31.9% |
| Mar 31, 2011 |
81.7% |
44.2% |
57.1% |
30.8% |
56.8% |
87.0% |
30.0% |
| Jun 30, 2011 |
57.8% |
99.0% |
94.9% |
80.5% |
75.1% |
94.8% |
72.7% |
| Sep 30, 2011 |
76.1% |
53.4% |
87.5% |
92.3% |
76.7% |
81.3% |
77.3% |
|
|
|
|
| |
|
|
| |
|
N/C = "Not Compliant",
and means Algis Ratnikas's Biotech Mutual Fund wasn't compliant for that period.
 A
blue star means Algis Ratnikas's Biotech Mutual Fund was in
the top 100 funds for that period.
A
green star means Algis Ratnikas's Biotech Mutual Fund was in
the top 25%.
The numbers above are the percentage of compliant funds that Algis Ratnikas's Biotech Mutual Fund
beat in the given time period, unless it was in the top 100 for that
period, in which case the number displays your rank. |
| |
|
|
|
|
alpha/beta vs. S&P500
|
|
|
| |
|
| For an explanation of alpha and beta, see the entry for "beta" in our glossary. |
| Alpha |
-0.57% |
| Beta |
0.99 |
| R-Squared |
0.62 |
|
|
|
|
|
| |
|
|
|
|
turnover
|
|
|
| |
|
| Last Month |
0.00% |
| Last 3 Months |
0.00% |
| Last 6 Months |
0.00% |
| Last 12 Months |
0.00% |
|
|
|
|
|
| |
|
|
|
|
about this fund profile |
|
|
| |
|
The fund profiled is managed by
aratnikas. It is a virtual fund on Marketocracy's website www.marketocracy.com that began with $1 million in cash and a Net Asset Value (NAV) of $10 per share.
Marketocracy is the only financial website where you can simulate running your own mutual fund and accurately compare your investing skill to professionally managed mutual funds and other investors. At Marketocracy, you can manage a $1 million virtual portfolio and make trades in an environment that mirrors the trading activity of the real stock market. Our portfolio management tools help you discover your investing strengths and weaknesses and help you become a better investor. You can try different investment strategies and styles to see what works best for you in a virtual environment first, before you invest your real money. It's a great place to learn, and a great place to prove your talent.
If your track record turns out to be one of the best, you will receive special privileges on our website and the best of the best get paid. If you're serious about investing or want to become a better investor, you'll want to signup for a free basic membership and start running your own fund. |
| |
|
[ To signup for your own virtual fund click here ]
|
| |
|
Who is Marketocracy?
Marketocracy Data Services is a research company whose mission is to find the best investors in the world and then track, analyze, and evaluate their trading activity. The company's affiliate, Marketocracy Capital Management, is the investment advisor for the Marketocracy family of mutual funds and uses the research generated by Marketocracy Data Services.
|
| |
|
[ For more information about Marketocracy ]
|
| |
|
|
|
![[marketocracy]](/images/topnav/mlogo.gif){kind=small}
![[marketocracy]](/images/homepage/mlogo_footer.gif){kind=small}
![[comstock data]](/images/portfolio/ComStock_Logo.gif){kind=logo}